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Abstract
Background: The literature presents many different algorithms for classifying heartbeats from
ECG signals. The performance of the classifier is normally presented in terms of sensitivity,
specificity or other metrics describing the proportion of correct versus incorrect beat
classifications. From the clinician's point of view, such metrics are however insufficient to rate the
performance of a classifier.
Methods: We propose a new methodology for the presentation of classifier performance, based
on Bayesian classification theory. Our proposition lets the investigators report their findings in
terms of beat-by-beat comparisons, and defers the role of assessing the utility of the classifier to
the statistician. Evaluation of the classifier's utility must be undertaken in conjunction with the set
of relative costs applicable to the clinicians' application. Such evaluation produces a metric more
tuned to the specific application, whilst preserving the information in the results.
Results: By way of demonstration, we propose a set of costs, based on clinical data from the
literature, and examine the results of two published classifiers using our method. We make
recommendations for reporting classifier performance, such that this method can be used for
subsequent evaluation.
Conclusion:  The proportion of misclassified beats contains insufficient information to fully
evaluate a classifier. Performance reports should include a table of beat-by-beat comparisons,
showing not-only the number of misclassifications, but also the identity of the classes involved in
each inaccurate classification.
Background
In recent years there has been a surge of interest in com-
puter implementations of automatic beat classification
algorithms. The impetus for this research stems partly
from the advances and miniaturisation of electronics,
which allows portable, wearable and implantable devices
to perform greater functionality than was achievable in
the past, but also from the desire to automate tasks cur-
rently performed by intensive care and operating room
staff.
There are several principles on which classifiers operate,
and many variations and implementations of each. With
the large number of published algorithms comes the need
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to analyse and compare their performance. The literature
to date, compares techniques on a low level, parameter-
by-parameter basis [1-3]. ANSI standard EC57 [4]
attempts to formalise methods for reporting such compar-
isons. These comparisons are of interest to those working
on the development of new algorithms or the enhance-
ment of existing ones, but are of little interest to a clinician
when making a decision about which algorithm suits his
purpose.
Problems with current classification methods
The contemporary method for reporting the performance
of a beat classification algorithm involves beat-by-beat
comparisons between the class as indicated by the algo-
rithm and as indicated by some reference. The MIT-BIH
database [5] is a commonly used reference source. Per-
formance is reported either by a table giving counts of cor-
rectly and incorrectly classified beats, or by way of
statistics inferred from such a table. Common statistics are
sensitivity (Se), specificity (Sp) and positive predictivity
(+P). These are defined as:
where:
TP = number of true positives
FP = number of false positives
TN = number of true negatives
FN = number of false negatives.
However these values are defined only for binary classifi-
cation, and do not readily lend themselves to problems
involving more than two classes, {ω1, ω2 ... ωn}. Neverthe-
less, in the literature, one often sees beat classifier per-
formance reports where sensitivity and specificity are
freely quoted. Whilst the definitions of these measures for
the context are normally not given, they appear to use the
following extended definitions:
TPj = number of beats correctly identified as belonging to
class ωj
FPj = number of beats incorrectly identified as belonging
to class ωj
TNj = number of beats correctly identified as belonging to
a class other than ωj
FNj = number of beats incorrectly identified as belonging
to a class other than ωj
and hence Sej, Spj and +Pj can be defined accordingly.
A number of problems become apparent when using such
statistics to evaluate the performance of beat classifiers:
1. They do not take into account the a priori probabilities
of the beat classes.
2. They do not take into account the relative costs of false
classification.
3. They can be presented only as a multi-dimensional
value, even where only two classes are being considered.
There is no obvious single ordinal value.
Problem 1 has been recognised in the medical literature
[6]. We are not aware of any previous attempt to deal with
problem 2. Problem 3 makes these reports particularly
unhelpful from the point of view of the clinician trying to
compare systems with a view to adopting one for use. For
an n class classifier, there are 2n scalar quantities, so rank-
ing classifiers using these quantities is not possible.
We propose a new method, which overcomes these prob-
lems and aims to be generally useful for the quantitative
comparison of beat classification schemes.
Proposed methodology
A system's utility as a prognostic medical tool is a measure
of the benefit afforded by selecting it against other alterna-
tives. Choosing a system involves maximising the benefit,
or alternatively, minimising the risk. A measure for the
overall risk associated with making a decision based upon
the output of a beat classifier is a useful measure of its per-
formance. Risk is characterised by the probability of error
and the costs associated with making a decision based
upon the erroneous classification. We have used Bayesian
decision theory to determine a method of calculating the
risk associated with a beat classifier.
Introduction to Bayesian risk
Bayesian decision theory is presented in many texts on sta-
tistics and classification theory [7,8] and will be intro-
duced here only briefly. In a system which is claimed to
recognise n different classes of beats {ω1, ω2 ...ωn}, there
are n possible outputs, {α1, α2 ... αn}. Bayes rule states:
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Since {α1,  α2  ...  αn} are mutually exclusive and
 then
The quantity P(ωj) is called the a priori probability,
P(αk|ωj) the likelihood or class conditional probability and
P(ωj|αk) the a posteriori probability. Note that P(αj|ωj) ≡
Sej . From (1) and (2) we can write:
Let λ(αk|ωj) be the cost incurred for making decision αk
when ωj is the true beat class. Therefore, the risk of making
decision αk based upon the classifier's output (the risk of
reliance) is:
Combining the above gives
The overall risk of relying on a classifier is
or equivalently
We propose that {R(α1), R(α2) ... R(αn)} be used in the
consideration of a classifier's utility, and that   be used
for overall rating of classifiers.   has the range (0, ∞) and
its units are dollars (or whatever units have been chosen
for λ(αk|ωj)). We envisage that a unitless measure, having
the range (0, 1) is more useful in many circumstances.
Accordingly, we also propose a normalised metric:
where   is the value obtained from equation (5)
when the class conditional probabilities are set to
Thus, a perfect classifier has a   value of zero and, at the
opposite extreme, unity.
Results
ANSI EC57 section 4.3 identifies 5 classes of beats which
are recommended in performance reports, viz:  normal
beats, Supra-Ventricular Ectopic Beats, Ventricular Ectopic
Beats, fusions of normal and Ventricular Ectopic Beats and
other unclassified beats. From secondary data sources, we
derived a priori probabilities and costs of decisions for
these classes. A detailed description of the derivation and
the data sources are below.
Table 1 shows the a priori probabilities. Table 2 shows the
costs. Together with the values of P(αk|ωj), these tables
enable the risk to be calculated. Unfortunately, in many
cases the literature presents neither the values for P(αk|ωj),
nor the table of beat-by-beat comparisons from which
they could be deduced. In the literature, we were able to
find only two classifiers for which this data was reported.
These are the classifiers of de Chazal et al. [9] and of Melo
et al. [10]. Melo et al. publishes separate results for aber-
rated atrial premature beats. For the purposes of compar-
ison, we have regarded aberrated and non-aberrated atrial
premature beats as a single class (ωSVEB).
The results are shown in Table 3. In these results, the over-
all risk   is significantly lower for the Melo classifier, and
the risks of reliance R(αi) is also lower for all i. In other
words, this classifier dominates in all respects. In general
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Table 1: A priori probabilities derived from the MIT-BIH 
Arrhythmia Database.
j ωj cj P(ωj)
0 Not a Beat 577 .
1 (N) Normal Beat 46097 0.9670
2 (SVEB) Supra Ventricular Ectopic Beat 192 0.0040
3 (VEB) Ventricular Ectopic Beat 1345 0.2800
4 (F) Fusion of Normal and VEB 13 0.0002
5 (Q) Unclassified Beat 0 0.00BMC Medical Informatics and Decision Making 2008, 8:7 http://www.biomedcentral.com/1472-6947/8/7
Page 4 of 8
(page number not for citation purposes)
however this may not be the case, and one classifier may
have a lower risk of reliance for one decision whilst having
a higher risk of reliance for another.
Discussion
We do not presume that the costs presented herein, or the
propositions used in their calculation are universally
applicable. Rather, we seek to demonstrate how, given the
class conditional matrix, an ordinal measure for a beat
classifier may be determined, applicable to any particular
situation. Others might disagree with our cost calculation
methods, or the application might demand consideration
for classes other than those we have investigated. Whilst
we have used monetary units to measure costs, we recog-
nise the ethical issues raised by doing so, and our method-
ology imposes no requirement on the nature of the units
of cost. Any unit acceptable to the community of interest
may be used. In such cases, given the class conditional
matrix, potential users may conduct their own studies and
assess the performance of the classifier using the method
we have described.
To facilitate such studies, we urge biomedical engineers to
report more than the relative numbers of correct versus
incorrectly classified beats, but also the identity of the
misclassified beats in the form of a class conditional
matrix. ANSI EC57 describes how to compile such a
matrix, but makes no recommendation for its publica-
tion. It is trivial to calculate sensitivity and specificity from
such a matrix if desired, and allows for more useful meas-
ures of performance as described herein. We recommend
publication of the class conditional matrix and/or a table
of beat-by-beat comparisons.
Conclusion
The utility of a beat classifier cannot be fully quantified in
terms of the number of correct and incorrect beats.
Instead, the number of misclassifications for each class is
required. Together with the a priori probabilities and the
costs of misclassification, quantitative measures of a clas-
sifier's utility can be determined.
A system which claims to classify beats into more than
two classes is not a binary classifier, and performance
should not be reported as if it is. Instead of reporting sen-
sitivity/specificity/predictivity for each of the n classes, a n
× n matrix of beat classifications (the class conditional fre-
quencies) should be reported.
Clinicians wishing to assess a classifier need to obtain esti-
mates for the costs of misclassification, and calculate the
overall risk of reliance.
Methods
Equation (5) comprises the terms P(αk|ωi),  P(ωj) and
λ(αk|ωj). P(αk|ωi) are parameters of the classifier and can
be tested experimentally. P(ωj) and λ(αk|ωj) are parame-
ters of the classes of interest. They are respectively the a pri-
ori probabilities and the costs of making decisions. In this
section we examine a number of secondary sources to
determine values for P(ωj) and λ(αk|ωj).
A priori probabilities
We used the MIT-BIH Arrhythmia Database to extract a
priori  probabilities. The records chosen were the first
group of records (numbers 100–124) from the database.
We omitted the second group (numbers 200–234), since
these were deliberately selected by the authors of the data-
base to contain "rare but clinically important phenom-
ena", whereas the first group was randomly selected so as
to "serve as a representative sample of the variety of wave-
forms and artifact that an arrhythmia detector might
encounter in routine clinical use".
Table 1 shows the data extracted from the database. Class
0 was disregarded, since these annotations are not beats,
but are used to mark other interesting features in the sig-
nal. cj are the counts of beats of class ωj. P(ωj) was calcu-
Table 2: Costs of false classification in 1000s of AUD
λω N ωSVEB ωVEB ωF ωQ
αN 03 8 . 6 3 1 170.192 170.193 0
αSVEB 0 0 170.194 170.195 0
αVEB 2.156 2.157 00 0
αF 2.158 2.159 00 0
αQ 00 0 0 0
1 Datum 5
2 Datum 13
3 Datum 13
4 Datum 13
5 Datum 13
6 Datum 14
7 Datum 14
8 Datum 14
9 Datum 14
Table 3: Comparative performance of two classifiers
Chazal et al.M e l o   et al.
R(αN) 2.05 1.67
R(αSVEB) 65.46 17.91
R(αVEB) 0.07 0.03
R(αF) 1.79 0.71
6.67 1.71
0.126 0.033
RP kk j j k
j
n
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lated by dividing cj by  , Note that c5 = 0 and we
therefore conclude that beat classes other than 1–4 are
sufficiently rare to have negligible effect on the utility of a
system.
Extrapolation of data
Where possible, we referred to longitudinal studies, giving
data gathered over a period of 10 years or longer. In many
instances, the data was available only in graphical form in
which case trapezoidal approximation of integrals was
used. Where data over a 10 year period was not available,
we used data gathered over a shorter period and extrapo-
lated by the following method.
We presume survival to be described by an exponential
expression 
s = κeβt.                        (10)
where κ and β are constants for which β < 0 and 0 <κ ≤ 1.
Equation (10) implies that the mortality fraction m is
m = 1-κeβt.                      (11)
Integrating m over 10 years gives the total loss:
which can be expressed as
where X = ln κ. Thus equation (10) implies
ln(s) = X + βt.           (14)
Hence, X and β can be found from the data by linear
regression of t against ln(s), and the total expected mortal-
ity over 10 years from equation (13).
Costs of incorrect classification
In determining costs for incorrect decisions, we have pre-
sumed standard clinical treatment of abnormal beats, or
non-treatment of normal beats according to the system's
output. We have then investigated the costs, in monetary
terms, of taking that course of action under each state of
nature. We have endeavoured to report 'costs' as the gen-
eral cost to society, rather than the cost to any particular
entity. A summary of these figures is presented in Table 2.
All costs have been normalised the year 2006, and are in
Australian dollars except where otherwise noted.
Each application however may have different ancillary
parameters, and these may affect the costs involved. The
methods and figures provided in this study reflect the
most general situation, as best as we could determine.
Propositions we have made in calculations of costs we
have stated herein, and these should be examined when
applying the figures.
Proposition 1 The clinical treatment for fusions of normal
and Ventricular Ectopic Beats (class ωF) is identical to that for
Ventricular Ectopic Beats.
We make this proposition on the basis that sustained Ven-
tricular Ectopic Beats are potentially life threatening, and
must be treated. To a clinician, the fact that the polarisa-
tion of the waveform coincides with the preceding beat is
merely incidental.
Proposition 2 The maximum future projection which may
affect costs of misclassification is 10 years.
10 years is chosen as a reasonable period beyond which
the advances in medical technology can be expected to
invalidate the results of future prediction.
Datum 1 The expected loss of life of a healthy subject, projected
over the next 10 years, is 1.21 years.
This datum is from the control group of Benjamin et al.
[11]. This was a longitudinal study which investigated the
mortality of subjects who had developed Atrial Fibrilla-
tion. We integrated the survival results presented by Figure
A of that paper to determine the expected number of years
of life lost by a healthy subject.
Datum 2 The probability that a subject with Supra-Ventricular
Ectopic Beats will develop Atrial Fibrillation is 0.324.
Datum 2 comes from the results of Frost et al. [12].
Datum 3 The expected loss of life due to a person suffering
from Atrial Fibrillation is 2.69 years (projected over 10 years).
Datum 3 is determined from Benjamin et al. in a similar
fashion to Datum 1: The calculations are presented in
Table 4.
Datum 4 A person's contribution to society is $44,320 per
annum.
Datum 4 is the mean average wage in Australia for the year
2006[13].
Datum 5 The cost of misdiagnosing a Supra-Ventricular
Ectopic Beat as a normal beat, λ(αN|ωSVEB) is $38,627.
c j 1
5 ∑
1
0
10
− ∫ κ
β ed t
t , (12) (12)
10 1
10 −−
× eX
e
β
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This figure is the product of Data 2, 3 and 4.
Datum 6 The probability of initially surviving Ventricular
Fibrillation is  .
From the text of Baum et al.[14], we know that, in a 3 year
study of Ventricular Fibrillation cases, 146 patients out of
886 initially survived Ventricular Fibrillation.
Datum 7 The total expected loss of life by a person who initially
survives Ventricular Fibrillation is 6.33 years (projected over
10 years).
To derive Datum 7 we used the results of Baum et al.[14].
In Figure 2 of that paper, survival curves are presented for
subjects who initially survived Ventricular Fibrillation.
Survival data are presented for only 24 months. We
extrapolated survival data over a 10 year period by the
method described above.
Datum 8 The expected loss of life, attributable to Ventricular
Fibrillation, by a subject who suffers Ventricular Fibrillation is
8.19 years (projected over 10 years).
We know from Datum 3 that the expected loss of life of
healthy subjects is 1.21 years. Hence we can calculate the
loss due to Ventricular Fibrillation as per Table 5.
Datum 9 The expected loss of life, attributable to Ventricular
Tachycardia by a subject who suffers Ventricular Tachycardia is
2.59 years (projected over 10 years).
This datum was obtained from Doval et al.[15] by the data
extrapolation method described previously. In that study
of 516 subjects both with and without non-sustained Ven-
tricular Tachycardia, the projected loss over 10 years for
the group with Ventricular Tachycardia was 9.24 years,
whereas the projected loss for the group without Ventricu-
lar Tachycardia was 6.65 years. The difference is 2.59
years.
Datum 10 The probability that a subject who experiences one
or more episodes of Ventricular Ectopic Beats, will develop Ven-
tricular Fibrillation is 0.34.
Datum 11 The probability that a subject who experiences one
or more episodes of Ventricular Ectopic Beats, will develop Ven-
tricular Tachycardia is 0.41.
Datum 10 and Datum 11 are implied from Carrim and
Khan [16]. In that study of 44 subjects exhibiting Ven-
tricular Ectopic Beats, V T is the set of subjects developing
Ventricular Tachycardia and V F is the set of subjects
developing Ventricular Fibrillation. From their data, we
are given:
|V T ∪ V F| = 21, (15)
(15)
and
from which we can deduce that |V T ∩ V F| = 12, |V T| =
18 and |V F| = 15.
Thus,
and
Datum 12 The expected loss of life, when a Ventricular Ectopic
Beat is misdiagnosed as a normal beat is 3.84 years.
Datum 12 is derived from Data 10, 11, 8 and 9. The deri-
vation is shown in Table 6.
Datum 13 The cost of misdiagnosing a Ventricular Ectopic
Beat as a normal beat, λ(αN|ωVEB) is $170,189.
146
886 0 164 = .
VT VF ∩= 6, (16) (16)
VF VT ∩= 3, (17) (17)
PV T
VT
() VEB x ==

18
44
(18) (18)
PV F
VF
() . VEB x ==

15
44
(19) (19)
Table 4: Expected Loss of life due to Atrial Fibrillation
Women without Atrial Fibrillation 0.87
Men without Atrial Fibrillation 1.55
Mean Average 1.21
Women with Atrial Fibrillation 3.75
Men with Atrial Fibrillation 4.05
Mean Average 3.90
Expected Loss Due to AF 2.69
Table 5: Expected Loss of life due to Ventricular Fibrillation
Group P loss of life Expectation
Survival 0.161 × 6.362 = 1.04
Non-survival 0.84 × 10 = 8.40
Healthy subject (1.21)3
Total loss due to VF 8.19
1Datum 6
2Datum 7
3Datum 1BMC Medical Informatics and Decision Making 2008, 8:7 http://www.biomedcentral.com/1472-6947/8/7
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This is the product of Datum 12 and Datum 4. By Propo-
sition 1 we attribute the same cost to λ(αN|ωF).
Costs of misclassification of a normal beat as abnormal
Ventricular Ectopic Beats are of potential concern to a
physician. If a system misclassifies a normal beat (ωN), or
a Supra-Ventricular Ectopic Beat (ωSVEB) as Ventricular
Ectopic Beat or a fusion beat (decisions αVEB and αF), the
likely result is that the patient will be unnecessarily
detained in observation, pending further examination.
Thus, the cost of misclassification, in this case, is the cost
of retaining a patient in intensive care for one day.
Datum 14 The cost of retaining a patient in intensive care for
1 day is $2146
This datum is the mean average of figures obtained from
two independent Australian health insurance providers. A
case study by Rechner and Lipman[17] for the year 2003
cites the figure $2670. This study however was conducted
within a teaching hospital, and we therefore expect the
costs to be higher than average.
We use the cost of retaining a patient in intensive care for
one day as the cost of misclassification of a normal beat as
the penalty in such instances. Thus λ(αVEB|ωN) = λ(αF|ωN)
= λ(αVEB|ωSVEB) = λ(αF|ωSVEB) = $2146.
From Proposition 1 we conclude that λ(λ(αF|ωVEB) =
λ(αVEB|ωF) = 0.
Erroneous classification of beats as Supra-Ventricular Ectopic Beats
Unlike Ventricular Ectopic Beats, Supra-Ventricular
Ectopic Beats are typically not life threatening, and are
therefore not normally treated unless recurrent [18]. Thus,
the cost of misclassification as a normal beat
(λ(αSVEB|ωN)) is zero. By the same token, misclassification
of Ventricular Ectopic Beats or fusion beats as Supra-Ven-
tricular Ectopic Beats bears the same penalty as an errone-
ous classification as a normal beat. Thus λ(αSVEB|ωVEB) =
λ(αN|ωVEB) and λ(αSVEB|ωF) = λ(αN|ωF).
Upper bound of risk
From Tables 1 and 2, the value of   was calculated as
described in section as $52,817.
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